Cellular basis of dynamic, infravesical obstruction in BPH: Role of adrenoceptor blockers and intracellular second messengers;Zelluläre grundlage der dynamischen, infravesikalen obstruktion im rahmen der benignen prostatahyperplasie: Rolle von alpharezeptorenblockern und zyklischen nukleotiden

Aktuelle Urologie

Volumn 29, Issue 5, 1998, Pages 252-260

  Eckert, R E ^a   Schreier, U ^a   Alloussi, Sch ^a   Ziegler, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Adrenoceptor blocker; BPH; Patch clamp; Signal transduction; Smooth muscle

Indexed keywords

EID: 0032394035     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065296     Document Type: Article

References (29)

1. Melchior H. Kostenentwicklung im deutschen Gesundheitswesen. Dt. Ges. Urol. Mitt. 1995, 206-208
2. Forray C, Bard JA, Wetzel JM, Chiu G, Shapiro E, Rang R, Lepor H, Hartig PR, Weinschank R, Branchek TA, Gluchowski C. The alpha-1 adrenergic receptor that mediates smooth muscle contraction in the human prostate has the pharmacological properties of the cloned human alpha-1C subtype. Mol. Pharmacol. 1994, 45: 703-708
3. Chapple CR, Aubry M, James S, Greengrass PM, Burnstock G, Turner-Warwick RT, Milleroy EJG, Cavej MJ. Characterization of human prostatic adrenoceptors using pharmacology receptor binding and localization. Br. J. Urol. 1989, 63: 487-496.
4. Chapple CR, Burt RP, Andersson PO, Greengrass P, Wyllie M, Marshall I. Alpha1 adrenoceptor subtypes in the human prostate. Br. J. Urol. 1994, 74: 585-589
5. Price DT, Schwinn DA, Lomasney JW, Allen LF, Caron MG, Lefkowitz RJ. Identification, quantification, and localisation of mRNA for three distinct alpha-1 adrenergic receptor subtypes in human prostate. J. Urol. 1993, 150: 546-551
6. Caine M, Perlberg S, Shapiro A. Phenoxybenzamine for benign prostatic obstruction. Urology 1981, 17: 542-546
7. 1A-adrenoceptor antagonist. Eur Urol 1996, 29: 145-154
8. 1A-adrenoceptor antagonist. Eur Urol 1996,29:155-167
9. Martin DJ, Angel I, Arbilla S. Functional uroselectivity. Eur Urol 1998, 33(suppl2): 12-18
10. Andersson KE. The concept of uroselectivity.Eur Urol 1998, 33(suppl2): 7-11
11. i in smooth muscle. Ann. Rev. Physiol. 1989, 51: 315
12. Walsh MP. Calcium regulation of smooth muscle contraction. In: Marne D (ed) Calcium and cell physiology. Berlin Springer Verlag, 1985, 123
13. Shima H, Blaustein MP. Modulation of evoked contractions in rat arteries by ryanodine, thapsigargin and cyclopiazonic acid. Circ. Res. 1992, 70(5): 969
14. Hamill OP, Marty A, Neher E, Sakmann FJ. Improved patch-clamp techniques for high resolution current recordings from cells and cell-free membrane patches. Pflügers Arch. 1981, 391: 395
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260: 3440-3450
16. Neher E. Combined fura-2 and patch-clamp measurements in rat peritoneal mast cells. Neuromuscular junction, Eds. Sellin, L.C., Libelius, R., Thesleff, 1987, 65-76
17. 2+ in individual small cells using fluorescence microscopy with dual excitation wavelength. Cell calcium 1985, 6: 145-157
18. Kamm KE, Stull JT. Regulation of smooth muscle contractile elements by second messengers. Ann. Rev. Physiol. 1989, 51: 299
19. Ignarro LJ, Kadowitz. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann. Rev. Pharmacol. Toxicol. 1989, 25: 171-191
20. Light DB, Corbin JD, Stanton BA. Dual ion-channel regulation by cyclic GMP and cyclic GMP dependent protein kinase. Nature 1990, 344: 61-67
21. Lincoln TM. Cyclic GMP and mechanisms of vasodilatation. Pharmacol. Ther. 1989, 41: 479-502
22. Berridge MJ, Irvine R. Inositol trisphosphate, a novel second messenger in cellular cell signal transduction. Nature 1984, 312: 315-321
23. Berridge MJ. Inositol trisphosphate and diacylglycerol: Two interacting second messengers. Ann. Rev. Biochem. 1987, 56: 159-193.
24. Iino M, Kobayashi T, Endo M. Use of ryanodine for functional removal of the calcium store in smooth muscle cells of the guinea-pig. Biochem. Biophys. Res. Commun. 1988, 152: 417
25. Hisayama T, Takayanagi I. Ryanodine: its possible mechanism of action in the caffeine-sensitive calcium store of smooth muscle. Pflügers Arch. 1988, 412: 376
26. Bian J, Gosh TK, Wang JC, Gill DL. Identification of intracellular calcium pools: selective modification by thapsigargin. J. Biol. Chem. 1991, 266: 8801-8806
27. 1-adrenoceptors: consensus update. Pharmacol. Rev. 1995, 47: 267-270
28. Lin VK, Benaim E, Soboorian H, McConnell JD. Apha blockade down regulates smooth muscle heavy chain gene expression in human BPH. J. Urol. 1996, 155: 587A
29. Lepor H. und die VA Cooperative Studies BPH Study Group. A Department of Veterans Affairs (VA) cooperative randomized placebo controlled clinical trial of the safety and efficacy of terazosin and finasteride monotherapy and terazosin/finasteride combination therapy in men with clinical BPH. J. Urol. 1996, 155: 587A